Search results for 29

Blood Group B antibody (HEB-29), Covalab, Ref 00113743

Biotin Anti-EPO antibody [EPR22931-29] (Detector), Abcam, AB322846

How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Tripartite Motif-Containing Protein 29 (TRIM29) Antibody, Abbexa, abx238978

TRIM29 Antibody is a Rabbit Polyclonal against TRIM29.

Anti-Cav1.3 Ca2+ channel Antibody (L48A/29), AntibodySystem, RHG63501

Anti-SK2 K+ channel Antibody (K78/29), AntibodySystem, RHN18202

Anti-KChIP3 K+ channel Antibody (K66/29), AntibodySystem, RHJ86702

Anti-HIF1 beta antibody [29/HIF-1b], Abcam, AB289550

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Want a custom formulation? This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact [email protected]

Ubiquitin Carboxyl-Terminal Hydrolase 29 (USP29) Antibody, Abbexa, abx031557

Modification of target proteins by ubiquitin participates in a wide array of biological functions. Proteins destined for degradation or processing via the 26 S proteasome are coupled to multiple copies of ubiquitin. However, attachment of ubiquitin or ubiquitin-related molecules may also result in changes in subcellular distribution or modification of protein activity. An additional level of ubiquitin regulation, deubiquitination, is catalyzed by proteases called deubiquitinating enzymes, which fall into four distinct families. Ubiquitin C-terminal hydrolases, ubiquitin-specific processing proteases (USPs), 1 OTU-domain ubiquitin-aldehyde-binding proteins, and Jab1/Pad1/MPN-domain-containing metallo-enzymes. Among these four families, USPs represent the most widespread and represented deubiquitinating enzymes across evolution. USPs tend to release ubiquitin from a conjugated protein. They display similar catalytic domains containing conserved Cys and His boxes but divergent N-terminal and occasionally C-terminal extensions, which are thought to function in substrate recognition, subcellular localization, and protein-protein interactions.

SAGA Complex Associated Factor 29 (SGF29) Antibody, Abbexa, abx310451

SGF29 Antibody is a Rabbit Polyclonal against SGF29.

Endoplasmic Reticulum Protein 29 (ERP29) Antibody (HRP), Abbexa, abx108213

Endoplasmic reticulum resident protein 29 Antibody (HRP) is a Rabbit Polyclonal antibody against Endoplasmic reticulum resident protein 29 conjugated to HRP.